{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,7]],"date-time":"2026-01-07T23:34:19Z","timestamp":1767828859443,"version":"3.49.0"},"reference-count":41,"publisher":"BMJ","issue":"9","license":[{"start":{"date-parts":[[2020,9,25]],"date-time":"2020-09-25T00:00:00Z","timestamp":1600992000000},"content-version":"unspecified","delay-in-days":24,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"funder":[{"DOI":"10.13039\/100011102","name":"Seventh Framework Programme","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100011102","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004046","name":"Karen Elise Jensens Fond","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100004046","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100006356","name":"Syddansk Universitet","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100006356","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Optimunise","award":["Health-F3-2011\u2013261375"],"award-info":[{"award-number":["Health-F3-2011\u2013261375"]}]},{"DOI":"10.13039\/501100000780","name":"European Commission","doi-asserted-by":"publisher","award":["ICA4-CT-2002-10053"],"award-info":[{"award-number":["ICA4-CT-2002-10053"]}],"id":[{"id":"10.13039\/501100000780","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100009708","name":"Novo Nordisk Fonden","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100009708","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001732","name":"Danmarks Grundforskningsfond","doi-asserted-by":"publisher","award":["DNRF108"],"award-info":[{"award-number":["DNRF108"]}],"id":[{"id":"10.13039\/501100001732","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000912","name":"March of Dimes Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000912","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100010663","name":"H2020 European Research Council","doi-asserted-by":"publisher","award":["Starting grant ERC-2009-StG-243149"],"award-info":[{"award-number":["Starting grant ERC-2009-StG-243149"]}],"id":[{"id":"10.13039\/100010663","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["bmj.com"],"crossmark-restriction":true},"short-container-title":["BMJ Glob Health"],"accepted":{"date-parts":[[2020,7,29]]},"published-print":{"date-parts":[[2020,9]]},"abstract":"<jats:sec>\n                  <jats:title>Introduction<\/jats:title>\n                  <jats:p>Receiving Bacille Calmette-Gu\u00e9rin (BCG)-Denmark vaccine at birth has been associated with ~40% reductions in all-cause neonatal mortality. We evaluated determinants of BCG skin reaction characteristics by age 2 months and tested the association with subsequent mortality.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Methods<\/jats:title>\n                  <jats:p>Prospective observational study amalgamating five trials providing BCG-at-birth that were conducted between 2002 and 2018 in Guinea-Bissau. The reaction status and size were evaluated at home-visits by 2 months of age among 6012 neonates; mortality from 2 to 12 months was assessed at subsequent visits. Reaction determinants were evaluated by binomial regression providing risk ratios (RRs). In Cox-models providing adjusted mortality rate ratios (aMRRs), we assessed the association between (1) having a 2-month reaction (yes\/no) and (2) reaction size tertiles and subsequent all-cause mortality risk. A subgroup had their BCG reaction evaluated and were bled at age 4 weeks; their samples underwent in vitro analysis for specific and non-specific cytokine responses.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Results<\/jats:title>\n                  <jats:p>The BCG strain was the main determinant for developing a 2-month reaction and the reaction size: the BCG-Russia\/BCG-Denmark RR for large-reaction was 0.38 (0.30\u20130.47) and the BCG-Russia\/BCG-Japan RR was 0.61 (0.51\u20130.72). 5804 infants (96.5%) were reactors by age 2 months; 208 (3.5%) were non-reactors. The 2\u201312 months mortality risk was 4.8% (10\/208) for non-reactors, 2.9% (64\/2213) for small reactors, 1.8% (30\/1710) for medium reactors and 0.8% (15\/1881) for large reactors. The reactor\/non-reactor aMRR was 0.49 (0.26\u20130.95) and there was a linear trend of decreasing mortality with increasing reaction size (p for trend &lt;0.001). BCG reactors had higher 4-week specific and non-specific cytokine responses, responses that were highest among those with large reactions.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Conclusion<\/jats:title>\n                  <jats:p>Among BCG-vaccinated infants, having a BCG skin reaction by age 2 months was associated with markedly better survival, as was the reaction size. Our findings thus support that BCG has substantial effects on all-cause mortality. Emphasising at-birth vaccination with immunogenic BCG strains and revaccinating non-reactors and small reactors could have major public health benefits.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Trial registration numbers<\/jats:title>\n                  <jats:p>\n                     <jats:ext-link xmlns:xlink=\"http:\/\/www.w3.org\/1999\/xlink\" ext-link-type=\"clintrialgov\" xlink:href=\"NCT00146302\">NCT00146302<\/jats:ext-link>, <jats:ext-link xmlns:xlink=\"http:\/\/www.w3.org\/1999\/xlink\" ext-link-type=\"clintrialgov\" xlink:href=\"NCT00168610\">NCT00168610<\/jats:ext-link>, <jats:ext-link xmlns:xlink=\"http:\/\/www.w3.org\/1999\/xlink\" ext-link-type=\"clintrialgov\" xlink:href=\"NCT00625482\">NCT00625482<\/jats:ext-link>, <jats:ext-link xmlns:xlink=\"http:\/\/www.w3.org\/1999\/xlink\" ext-link-type=\"clintrialgov\" xlink:href=\"NCT01989026\">NCT01989026<\/jats:ext-link> and <jats:ext-link xmlns:xlink=\"http:\/\/www.w3.org\/1999\/xlink\" ext-link-type=\"clintrialgov\" xlink:href=\"NCT02447536\">NCT02447536<\/jats:ext-link>.<\/jats:p>\n               <\/jats:sec>","DOI":"10.1136\/bmjgh-2020-002993","type":"journal-article","created":{"date-parts":[[2020,9,25]],"date-time":"2020-09-25T17:25:44Z","timestamp":1601054744000},"page":"e002993","update-policy":"https:\/\/doi.org\/10.1136\/crossmarkpolicy","source":"Crossref","is-referenced-by-count":29,"title":["BCG skin reactions by 2 months of age are associated with better survival in infancy: a prospective observational study from Guinea-Bissau"],"prefix":"10.1136","volume":"5","clinical-trial-number":[{"clinical-trial-number":"nct00146302","registry":"10.18810\/clinical-trials-gov"},{"clinical-trial-number":"nct00168610","registry":"10.18810\/clinical-trials-gov"},{"clinical-trial-number":"nct00625482","registry":"10.18810\/clinical-trials-gov"},{"clinical-trial-number":"nct01989026","registry":"10.18810\/clinical-trials-gov"},{"clinical-trial-number":"nct02447536","registry":"10.18810\/clinical-trials-gov"},{"clinical-trial-number":"nct01989026","registry":"10.18810\/clinical-trials-gov"}],"author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-7643-8322","authenticated-orcid":false,"given":"Frederik","family":"Schaltz-Buchholzer","sequence":"first","affiliation":[{"name":"Bandim Health Project, Institute of Clinical Research, Uni. Southern Denmark and Odense University Hospital, Odense, Denmark"},{"name":"Bandim Health Project, INDEPTH Network, Bissau, Guinea-Bissau"},{"name":"Research Centre for Vitamins and Vaccines, Copenhagen, Denmark"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9516-6190","authenticated-orcid":false,"given":"Mike","family":"Berendsen","sequence":"additional","affiliation":[{"name":"Bandim Health Project, Institute of Clinical Research, Uni. Southern Denmark and Odense University Hospital, Odense, Denmark"},{"name":"Bandim Health Project, INDEPTH Network, Bissau, Guinea-Bissau"},{"name":"Research Centre for Vitamins and Vaccines, Copenhagen, Denmark"},{"name":"Department of Internal Medicine, Radboud Centre for Infectious Diseases, Radboud University Medical Centre, Nijmegen, The Netherlands"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Adam","family":"Roth","sequence":"additional","affiliation":[{"name":"Public Health Agency of Sweden, Solna, Sweden"},{"name":"Institution for Translational Medicine, Lund University, Malm\u00f6, Sweden"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9687-5706","authenticated-orcid":false,"given":"Kristoffer Jarlov","family":"Jensen","sequence":"additional","affiliation":[{"name":"Bandim Health Project, Institute of Clinical Research, Uni. Southern Denmark and Odense University Hospital, Odense, Denmark"},{"name":"Experimental and Translational Immunology, Department of Health Technology, Technical University of Denmark, Lyngby, Denmark"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4128-5714","authenticated-orcid":false,"given":"Morten","family":"Bjerregaard-Andersen","sequence":"additional","affiliation":[{"name":"Bandim Health Project, INDEPTH Network, Bissau, Guinea-Bissau"},{"name":"Research Centre for Vitamins and Vaccines, Copenhagen, Denmark"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5775-8854","authenticated-orcid":false,"given":"Marcus","family":"Kj\u00e6r S\u00f8rensen","sequence":"additional","affiliation":[{"name":"Bandim Health Project, INDEPTH Network, Bissau, Guinea-Bissau"},{"name":"Research Centre for Vitamins and Vaccines, Copenhagen, Denmark"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ivan","family":"Monteiro","sequence":"additional","affiliation":[{"name":"Bandim Health Project, INDEPTH Network, Bissau, Guinea-Bissau"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8331-1389","authenticated-orcid":false,"given":"Peter","family":"Aaby","sequence":"additional","affiliation":[{"name":"Bandim Health Project, INDEPTH Network, Bissau, Guinea-Bissau"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6102-3810","authenticated-orcid":false,"given":"Christine","family":"Stabell Benn","sequence":"additional","affiliation":[{"name":"Bandim Health Project, Institute of Clinical Research, Uni. Southern Denmark and Odense University Hospital, Odense, Denmark"},{"name":"Bandim Health Project, INDEPTH Network, Bissau, Guinea-Bissau"},{"name":"Research Centre for Vitamins and Vaccines, Copenhagen, Denmark"},{"name":"Danish Institute of Advanced Science, University of Southern Denmark, Odense, Denmark"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"239","published-online":{"date-parts":[[2020,9,25]]},"reference":[{"key":"2025072914340101000_5.9.e002993.1","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1038\/mt.2016.18","article-title":"The BCG strain pool: diversity matters","volume":"24","author":"Bottai","year":"2016","journal-title":"Mol Ther"},{"key":"2025072914340101000_5.9.e002993.2","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.i5170"},{"key":"2025072914340101000_5.9.e002993.3","doi-asserted-by":"publisher","DOI":"10.1093\/cid\/cix525"},{"key":"2025072914340101000_5.9.e002993.4","doi-asserted-by":"crossref","first-page":"624","DOI":"10.1093\/infdis\/jiy544","article-title":"Early BCG vaccination, hospitalizations, and hospital deaths: analysis of a secondary outcome in 3 randomized trials from Guinea-Bissau","volume":"219","author":"Schaltz-Buchholzer","year":"2019","journal-title":"J Infect Dis"},{"key":"2025072914340101000_5.9.e002993.5","doi-asserted-by":"publisher","DOI":"10.1016\/j.it.2013.04.004"},{"key":"2025072914340101000_5.9.e002993.6","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.1202870109"},{"key":"2025072914340101000_5.9.e002993.7","doi-asserted-by":"publisher","DOI":"10.1016\/S0264-410X(03)00181-6"},{"key":"2025072914340101000_5.9.e002993.8","doi-asserted-by":"publisher","DOI":"10.1093\/ije\/dyh392"},{"key":"2025072914340101000_5.9.e002993.9","doi-asserted-by":"publisher","DOI":"10.1097\/01.ede.0000231546.14749.ab"},{"key":"2025072914340101000_5.9.e002993.10","doi-asserted-by":"crossref","first-page":"1733","DOI":"10.1111\/tmi.12614","article-title":"Tuberculin reaction and BCG scar: association with infant mortality","volume":"20","author":"Timmermann","year":"2015","journal-title":"Trop Med Int Health"},{"key":"2025072914340101000_5.9.e002993.11","doi-asserted-by":"publisher","DOI":"10.1093\/cid\/civ452"},{"key":"2025072914340101000_5.9.e002993.12","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1093\/jpids\/piy142","article-title":"Maternal priming: Bacillus Calmette-Gu\u00e9rin (BCG) vaccine scarring in mothers enhances the survival of their child with a BCG vaccine scar","volume":"9","author":"Berendsen","year":"2020","journal-title":"J Pediatric Infect Dis Soc"},{"key":"2025072914340101000_5.9.e002993.13","doi-asserted-by":"crossref","DOI":"10.1111\/joim.13084","article-title":"BCG-scarring and improved child survival: a combined analysis of studies of BCG scarring","author":"Benn","year":"2020","journal-title":"J Intern Med"},{"key":"2025072914340101000_5.9.e002993.14","doi-asserted-by":"publisher","DOI":"10.1016\/j.vaccine.2004.10.022"},{"key":"2025072914340101000_5.9.e002993.15","article-title":"Early vaccination with BCG-Denmark or BCG-Japan versus BCG-Russia to healthy newborns in Guinea-Bissau: a randomized controlled trial","author":"Schaltz-Buchholzer","year":"2019","journal-title":"Clin Infect Dis"},{"key":"2025072914340101000_5.9.e002993.16","doi-asserted-by":"crossref","DOI":"10.1186\/s12879-017-2641-0","article-title":"The association between Bacillus Calmette-Gu\u00e9rin vaccination (1331 SSI) skin reaction and subsequent scar development in infants","volume":"17","author":"Birk","year":"2017","journal-title":"BMC Infect Dis"},{"key":"2025072914340101000_5.9.e002993.17","doi-asserted-by":"publisher","DOI":"10.1164\/rccm.201104-0714OC"},{"key":"2025072914340101000_5.9.e002993.18","doi-asserted-by":"publisher","DOI":"10.1097\/INF.0b013e3182458289"},{"key":"2025072914340101000_5.9.e002993.19","doi-asserted-by":"publisher","DOI":"10.1093\/infdis\/jir240"},{"key":"2025072914340101000_5.9.e002993.20","unstructured":"U.S. National Library of Medicine . A randomized trial of providing BCG vaccination immediately. Available: https:\/\/clinicaltrials.gov\/ct2\/show\/NCT01989026 [Accessed 2 Jan 2019]."},{"key":"2025072914340101000_5.9.e002993.21","first-page":"72","article-title":"BCG vaccination","author":"Guerin","year":"1992","journal-title":"Child Trop"},{"key":"2025072914340101000_5.9.e002993.22","doi-asserted-by":"publisher","DOI":"10.1016\/j.vaccine.2018.03.009."},{"key":"2025072914340101000_5.9.e002993.23","doi-asserted-by":"publisher","DOI":"10.1136\/bmjopen-2018-028775"},{"key":"2025072914340101000_5.9.e002993.24","doi-asserted-by":"publisher","DOI":"10.1093\/infdis\/jiu508"},{"key":"2025072914340101000_5.9.e002993.25","unstructured":"World Health Organization . Verbal autopsy standards: the 2012 WHO verbal autopsy instrument, 2012. Available: http:\/\/www.who.int\/healthinfo\/statistics\/WHO_VA_2012_RC1_Instrument.pdf [Accessed 10 Oct 2019]."},{"key":"2025072914340101000_5.9.e002993.26","doi-asserted-by":"publisher","DOI":"10.1186\/1471-2172-9-59"},{"key":"2025072914340101000_5.9.e002993.27","doi-asserted-by":"crossref","first-page":"4586","DOI":"10.1016\/j.vaccine.2016.07.022","article-title":"Different effects of BCG strains - A natural experiment evaluating the impact of the Danish and the Russian BCG strains on morbidity and scar formation in Guinea-Bissau","volume":"34","author":"Frankel","year":"2016","journal-title":"Vaccine"},{"key":"2025072914340101000_5.9.e002993.28","doi-asserted-by":"publisher","DOI":"10.1080\/21645515.2018.1420843"},{"key":"2025072914340101000_5.9.e002993.29","doi-asserted-by":"publisher","DOI":"10.1016\/j.vaccine.2012.01.053"},{"key":"2025072914340101000_5.9.e002993.30","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0032567"},{"key":"2025072914340101000_5.9.e002993.31","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1097\/INF.0000000000002198","article-title":"Two randomized trials of the effect of the Russian strain of Bacillus Calmette-Gu\u00e9rin Alone or with oral polio vaccine on neonatal mortality in infants weighing <2000\u2009g in India","volume":"38","author":"Jayaraman","year":"2019","journal-title":"Pediatr Infect Dis J"},{"key":"2025072914340101000_5.9.e002993.32","doi-asserted-by":"publisher","DOI":"10.1016\/j.cell.2017.12.031"},{"key":"2025072914340101000_5.9.e002993.33","doi-asserted-by":"crossref","first-page":"322","DOI":"10.1016\/j.chom.2020.05.014","article-title":"BCG vaccination in humans elicits trained immunity via the hematopoietic progenitor compartment","volume":"28","author":"Cirovic","year":"2020","journal-title":"Cell Host Microbe"},{"key":"2025072914340101000_5.9.e002993.34","doi-asserted-by":"crossref","first-page":"2229","DOI":"10.1016\/j.vaccine.2019.11.060","article-title":"Licensed Bacille Calmette-Gu\u00e9rin (BCG) formulations differ markedly in bacterial viability, RNA content and innate immune activation","volume":"38","author":"Angelidou","year":"2020","journal-title":"Vaccine"},{"key":"2025072914340101000_5.9.e002993.35","doi-asserted-by":"publisher","DOI":"10.1016\/j.chom.2017.12.010"},{"key":"2025072914340101000_5.9.e002993.36","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-019-08659-3"},{"key":"2025072914340101000_5.9.e002993.37","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1080\/16549716.2017.1267964","article-title":"The real-life number of neonatal doses of Bacille Calmette-Gu\u00e9rin vaccine in a 20-dose vial","volume":"10","author":"Schaltz-Buchholzer","year":"2017","journal-title":"Glob Health Action"},{"key":"2025072914340101000_5.9.e002993.38","doi-asserted-by":"publisher","DOI":"10.1186\/1471-2458-14-1037"},{"key":"2025072914340101000_5.9.e002993.39","doi-asserted-by":"publisher","DOI":"10.1016\/j.vaccine.2015.02.056"},{"key":"2025072914340101000_5.9.e002993.40","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(09)60317-2"},{"key":"2025072914340101000_5.9.e002993.41","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1016\/j.ebiom.2017.07.012","article-title":"Co-administration of BCG and diphtheria-tetanus-pertussis (DTP) vaccinations may reduce infant mortality more than the WHO-schedule of BCG first and then DTP. A Re-analysis of demographic surveillance data from rural Bangladesh","volume":"22","author":"Aaby","year":"2017","journal-title":"EBioMedicine"}],"container-title":["BMJ Global Health"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1136\/bmjgh-2020-002993","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,7,29]],"date-time":"2025-07-29T21:34:14Z","timestamp":1753824854000},"score":1,"resource":{"primary":{"URL":"https:\/\/gh.bmj.com\/lookup\/doi\/10.1136\/bmjgh-2020-002993"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,9]]},"references-count":41,"journal-issue":{"issue":"9","published-online":{"date-parts":[[2020,9,25]]},"published-print":{"date-parts":[[2020,9]]}},"alternative-id":["10.1136\/bmjgh-2020-002993"],"URL":"https:\/\/doi.org\/10.1136\/bmjgh-2020-002993","relation":{},"ISSN":["2059-7908"],"issn-type":[{"value":"2059-7908","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,9]]}}}